- Home
- LII vs ICLR Comparison
LII vs ICLR Comparison
Compare LII & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LII
- ICLR
- Stock Information
- Founded
- LII 1895
- ICLR 1990
- Country
- LII United States
- ICLR Ireland
- Employees
- LII N/A
- ICLR N/A
- Industry
- LII Industrial Machinery/Components
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- LII Industrials
- ICLR Health Care
- Exchange
- LII Nasdaq
- ICLR Nasdaq
- Market Cap
- LII 17.4B
- ICLR 14.3B
- IPO Year
- LII 1999
- ICLR 1998
- Fundamental
- Price
- LII $472.09
- ICLR $162.73
- Analyst Decision
- LII Hold
- ICLR Buy
- Analyst Count
- LII 12
- ICLR 15
- Target Price
- LII $607.00
- ICLR $205.07
- AVG Volume (30 Days)
- LII 560.6K
- ICLR 963.3K
- Earning Date
- LII 10-22-2025
- ICLR 10-22-2025
- Dividend Yield
- LII 1.10%
- ICLR N/A
- EPS Growth
- LII 12.46
- ICLR N/A
- EPS
- LII 23.67
- ICLR 7.47
- Revenue
- LII $5,345,300,000.00
- ICLR $8,102,602,000.00
- Revenue This Year
- LII N/A
- ICLR N/A
- Revenue Next Year
- LII $7.61
- ICLR $0.89
- P/E Ratio
- LII $19.92
- ICLR $21.70
- Revenue Growth
- LII 3.77
- ICLR N/A
- 52 Week Low
- LII $466.88
- ICLR $125.10
- 52 Week High
- LII $689.44
- ICLR $228.29
- Technical
- Relative Strength Index (RSI)
- LII 31.77
- ICLR 40.46
- Support Level
- LII $466.88
- ICLR $155.00
- Resistance Level
- LII $498.78
- ICLR $167.43
- Average True Range (ATR)
- LII 15.22
- ICLR 6.33
- MACD
- LII -0.80
- ICLR -0.64
- Stochastic Oscillator
- LII 9.12
- ICLR 30.91
About LII Lennox International Inc.
Lennox International manufactures and distributes heating, ventilating, air conditioning, and refrigeration products to replacement (75% of sales) and new construction (25% of sales) markets. In fiscal 2024, residential HVAC was 67% of sales and commercial HVAC and Heatcraft refrigeration was 33% of sales. The company goes to market with multiple brands, but Lennox is the company's flagship HVAC brand. The Texas-based company is focused on North America after the sale of its European HVAC and refrigeration businesses in late 2023.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.